How big is the risk of peripheral neuropathy with fluoroquinolones?

That’s the question UK researchers were looking to answer with their large case-controlled study recently published in JAMA Neurology.

And – cutting to the chase – what’s the answer? Well, the risk isn’t huge but there is certainly a risk. And the association is worth bearing in mind if a patient develops peripheral neuropathy because the timing of this side-effect can be unpredictable, making the link less obvious.